FIELD: chemistry.
SUBSTANCE: invention relates to pharmaceutical chemistry, specifically to compounds constituting oxadiazole derivatives of deoxycholic acid by the formula I, wherein R constitutes Me or Ph.
I
EFFECT: technical result consists in expanding the range of prostatoprotective substances also exhibiting pleiotropic - anti-inflammatory and hypocholesterolemic effects.
1 cl
Title | Year | Author | Number |
---|---|---|---|
LOW-TOXIC 1,3,4-OXADIAZOLE DERIVATIVES OF DEOXYCHOLIC ACID WITH PROSTATE-PROTECTIVE AND ANTI-INFLAMMATORY ACTION | 2023 |
|
RU2819604C1 |
BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT FOR STIMULATING TISSUE REGENERATION AND RECOVERY OF DIMINISHED TISSUE FUNCTION | 2015 |
|
RU2647438C2 |
ANTIPROLIFERATIVE AGENT | 2012 |
|
RU2482857C1 |
ANTIPROLIFERATIVE AGENT | 2011 |
|
RU2519727C2 |
MEANS FOR PREVENTION AND TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | 2016 |
|
RU2612268C1 |
METHOD AND REMEDY FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2764850C1 |
BISAMIDE DERIVATIVE OF DICARBOXYLIC ACID AS AGENT STIMULATING TISSUE REGENERATION AND RESTORATION OF REDUCED FUNCTIONS OF TISSUES | 2016 |
|
RU2727142C2 |
METHOD FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA | 2014 |
|
RU2574014C2 |
NONSTEROID MODULATORS OF ANDROGEN RECEPTOR, METHOD OF PRODUCTION, PHARMECEUTICAL COMPOSITION THEREOF AND USE | 2006 |
|
RU2378250C2 |
PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PROSTATE PATHOLOGIES | 2017 |
|
RU2750992C2 |
Authors
Dates
2021-06-28—Published
2020-06-03—Filed